header-5.jpg
Home
About Us

More About Us

The Australian Prostate Cancer Research Centre – Queensland is an integrated, trandisciplinary, and comprehensive prostate cancer research centre. Based in Brisbane, the APCRC – Q is a joint venture between the Queensland University of Technology and the Princess Alexandra Hospital.

More >

Upcoming Events

May 24, 2012 APCRC - Q Seminar Series
Russell Strong Auditorium, Princess Alexandra Hospital
Jun 05, 2012 - Jun 06, 2012 TRI Symposium
the PACE building in Cornwall Street (next to PAH)
Jun 07, 2012 APCRC - Q Seminar Series - Guest Speaker on Palliative Care
Brian Emmerson Room, Level 4, PAH
Jun 13, 2012 - Jun 15, 2012 Prostate Action Forum (Invite Only)
Rotterdam, Netherlands
Jun 18, 2012 - Jun 21, 2012 BIO 2012
Brisbane Convention and Exhibition Centre, Brisbane Australia
More events >
March 11--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) and OncoGenex Pharmaceuticals, Inc. (Nasdaq: OGXI) have expanded their Phase III clinical trial of Custirsen for the treatment for castrate-resistant prostate cancer.
Study Unblinded: ZYTIGA (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer Second ZYTIGA Phase 3 Study to be Unblinded, Based on Unanimous Recommendation of Independent Data Monitoring Committe
SummaryBackgroundBone metastases are a major cause of morbidity and mortality in men with prostate cancer. Preclinical studies suggest that osteoclast inhibition might prevent bone metastases.
December 12, 2011 — An independent panel convened this week by the National Institutes of Health (NIH) has concluded that many men with localized, low-risk prostate cancer could have treatment delayed until warranted by disease progression.
But Concerns About ADT Treatment Remain for Heart Patients
But those with a history of heart disease, stroke may be at higher risk, researchers caution

APCRC-Q News

May 15, 2012 APCRC - Q Welcomes Co-Op Students

Recently, the Australian Prostate Cancer Research Centre – Queensland (APCRC – Q) welcomed four new students from Canada to undertake a work placement for eight months. More >

May 13, 2012 Presentation Award Rewarded to Ling

Dr Patrick Ling, a Vice Chancellor Research Fellow at the Australian Prostate Cancer Research Centre – Queensland, was awarded the “Best Oral Free Paper Presentation at the 8th Organization of Oncology and Translation Research Conference (OOTR) in Japan. More >

May 09, 2012 APCRC - Q's Visit from Dresden, Germany

Drs Froehner and Fuessel spoke at the APCRC - Q’s regular Seminar Series event on the 17th April to an audience of Researchers, Clinicians and general public about their current research in the area of prostate cancer. Dr Froehner shared his research on “Competing Mortality after Radical Prostatectomy”. More >

Mar 23, 2012 Movember in partnership with beyondblue seeks Expressions of Interest for the ASAP Initiative

$6.25 million collaborative network to improve the lives of men living with prostate cancer. More >

Feb 23, 2012 2012 Aus-CanPCRA Symposium - Registration now closes 30th March!

The Australian-Canadian Prostate Cancer Research Alliance (Aus-Can PCRA) Symposium will be held in North Queensland's Daydream Island from Friday 13th to Monday 16th April 2012. More >

More news…